{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:32:05Z","timestamp":1792989125077,"version":"4.5.0"},"reference-count":67,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Acta Neuropsychiatr."],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0924270822000308_as1\"><jats:title>Background:<\/jats:title><jats:p>Several augmentation strategies have been used to improve symptomatology in patients not adequately responding to clozapine. Several randomised controlled trials (RCTs) have evaluated the efficacy of different strategies to augment clozapine. This systematic review and meta-analysis reviewed the available RCTs that have evaluated the clinical efficacy of various pharmacological agents, non-pharmacological strategies (occupational therapy, cognitive behaviour therapy), and somatic treatment [electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation, etc.)] as augmenting agents to clozapine.<\/jats:p><\/jats:sec><jats:sec id=\"S0924270822000308_as2\"><jats:title>Methods:<\/jats:title><jats:p>Data were extracted using standard procedures, and risk of bias was evaluated. Effect sizes were computed for the individual studies.<\/jats:p><\/jats:sec><jats:sec id=\"S0924270822000308_as3\"><jats:title>Results:<\/jats:title><jats:p>Forty-five clinical trials were evaluated. The pooled effect size for various antipsychotic medications was 0.103 (95% CI: 0.288\u20130.493, <jats:italic>p<\/jats:italic> &lt; 0.001); when the effect size was evaluated for specific antipsychotics for which more than one trial was available, the effect size for risperidone was \u22120.27 and that for aripiprazole was 0.57. The effect size for lamotrigine was 0.145, and that for topiramate was 0.392. The effect size for ECT was 0.743 (CI: 0.094\u20131.392). Risk of bias was low (mean Jadad score \u2013 3.93). Largest effect sizes were seen for mirtazapine (effect size of 5.265). Most of the studies can be considered underpowered and limited by small sample sizes.<\/jats:p><\/jats:sec><jats:sec id=\"S0924270822000308_as4\"><jats:title>Conclusions:<\/jats:title><jats:p>To conclude, based on the findings of the present systematic review and meta-analysis, it can be said that compared to other treatment strategies, clozapine non-responsive patients respond maximum to mirtazapine followed by ECT.<\/jats:p><\/jats:sec>","DOI":"10.1017\/neu.2022.30","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T05:43:11Z","timestamp":1668577391000},"page":"65-75","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":17,"title":["Augmentation strategies for clozapine resistance: a systematic review and meta-analysis"],"prefix":"10.1017","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2714-2055","authenticated-orcid":false,"given":"Sandeep","family":"Grover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-7086","authenticated-orcid":false,"given":"Swapnajeet","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"S0924270822000308_ref16","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04935gry"},{"key":"S0924270822000308_ref64","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0109"},{"key":"S0924270822000308_ref9","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-44462003000100006"},{"key":"S0924270822000308_ref14","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-4358-1_23"},{"key":"S0924270822000308_ref22","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145710000490"},{"key":"S0924270822000308_ref11","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp116"},{"key":"S0924270822000308_ref2","first-page":"CD006324","article-title":"Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia","volume":"3","author":"Barber","year":"2017","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"S0924270822000308_ref36","doi-asserted-by":"publisher","DOI":"10.4103\/0971-8990.182096"},{"key":"S0924270822000308_ref61","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118822171"},{"key":"S0924270822000308_ref33","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.1.130"},{"key":"S0924270822000308_ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa053222"},{"key":"S0924270822000308_ref48","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.1.145"},{"key":"S0924270822000308_ref21","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.5.826"},{"key":"S0924270822000308_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(99)00026-4"},{"key":"S0924270822000308_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00367-9"},{"key":"S0924270822000308_ref30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7308.334"},{"key":"S0924270822000308_ref50","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1009"},{"key":"S0924270822000308_ref7","first-page":"270","article-title":"Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial","volume":"14","author":"Behdani","year":"2011","journal-title":"Archives of Iranian Medicine"},{"key":"S0924270822000308_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2018.11.005"},{"key":"S0924270822000308_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2015.10.037"},{"key":"S0924270822000308_ref19","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3282fcff2f"},{"key":"S0924270822000308_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.12.030"},{"key":"S0924270822000308_ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2012.11.006"},{"key":"S0924270822000308_ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108089816"},{"key":"S0924270822000308_ref44","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000042"},{"key":"S0924270822000308_ref60","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291716000398"},{"key":"S0924270822000308_ref25","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.14"},{"key":"S0924270822000308_ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2009.01.002"},{"key":"S0924270822000308_ref3","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn030"},{"key":"S0924270822000308_ref53","doi-asserted-by":"publisher","DOI":"10.1159\/000319814"},{"key":"S0924270822000308_ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0004867414560092"},{"key":"S0924270822000308_ref27","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0b013e31815abf34"},{"key":"S0924270822000308_ref52","doi-asserted-by":"publisher","DOI":"10.1177\/0004867418772351"},{"key":"S0924270822000308_ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.06.029"},{"key":"S0924270822000308_ref67","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200403000-00003"},{"key":"S0924270822000308_ref42","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110372548"},{"key":"S0924270822000308_ref65","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.16r10782"},{"key":"S0924270822000308_ref58","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.11.1822"},{"key":"S0924270822000308_ref40","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30184-6"},{"key":"S0924270822000308_ref12","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0505"},{"key":"S0924270822000308_ref34","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000345"},{"key":"S0924270822000308_ref5","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0b013e3181be7422"},{"key":"S0924270822000308_ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00601"},{"key":"S0924270822000308_ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s40501-019-0166-4"},{"key":"S0924270822000308_ref20","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-44462007000600002"},{"key":"S0924270822000308_ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(06)70524-7"},{"key":"S0924270822000308_ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.02.009"},{"key":"S0924270822000308_ref23","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04683"},{"key":"S0924270822000308_ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2018.08.002"},{"key":"S0924270822000308_ref10","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1176\/ajp.153.12.1625","article-title":"Fluoxetine augmentation of clozapine treatment in patients with schizophrenia","volume":"153","author":"Buchanan","year":"1996","journal-title":"The American Journal of Psychiatry"},{"key":"S0924270822000308_ref51","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.171.6.569"},{"key":"S0924270822000308_ref45","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318248dfb8"},{"key":"S0924270822000308_ref4","doi-asserted-by":"publisher","DOI":"10.3310\/hta21490"},{"key":"S0924270822000308_ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000165740.22377.6d"},{"key":"S0924270822000308_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2010.11.022"},{"key":"S0924270822000308_ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.08.005"},{"key":"S0924270822000308_ref55","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(03)00524-9"},{"key":"S0924270822000308_ref56","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0808"},{"key":"S0924270822000308_ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.04.005"},{"key":"S0924270822000308_ref49","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2019.11.336"},{"key":"S0924270822000308_ref68","first-page":"319","article-title":"Treatment-resistant schizophrenia: challenges and implications for clinical practice","volume":"27","author":"\u0160agud","year":"2015","journal-title":"Psychiatria Danubina"},{"key":"S0924270822000308_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"S0924270822000308_ref54","doi-asserted-by":"publisher","DOI":"10.1192\/pb.24.12.450"},{"key":"S0924270822000308_ref63","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.101"},{"key":"S0924270822000308_ref28","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200110000-00005"},{"key":"S0924270822000308_ref46","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.13060787"},{"key":"S0924270822000308_ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.12.011"}],"container-title":["Acta Neuropsychiatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0924270822000308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T11:15:48Z","timestamp":1678187748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0924270822000308\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0924270822000308"],"URL":"https:\/\/doi.org\/10.1017\/neu.2022.30","relation":{},"ISSN":["0924-2708","1601-5215"],"issn-type":[{"value":"0924-2708","type":"print"},{"value":"1601-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"\u00a9 The Author(s), 2022. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}